Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13Prostatic Neoplasms 9Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Endometrial Neoplasms 3Colorectal Neoplasms 3Cardiovascular Diseases 3Cardiotoxicity 3Triple Negative Breast Neoplasms 2Polycystic Ovary Syndrome 2Ovarian Neoplasms 2Melanoma 2Lymphoma, Non-Hodgkin 2Leukemia 2Kidney Neoplasms 2Heart Failure 2Endometrial Hyperplasia 2Carcinoma, Renal Cell 2Waldenstrom Macroglobulinemia 1Venous Thrombosis 1Urogenital Neoplasms 1Smoking 1Sarcoma 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Overall Survival 1Ototoxicity 1

Interventions

Cisplatin 3sodium thiosulfate 2Acetylcysteine 2Vorinostat 1Surveys and Questionnaires 1Radiosurgery 1Pantoprazole 1Methotrexate 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Hearing Tests 1Genetic Association Studies 1Dexamethasone 1Audiometry 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ototoxicity × Atorvastatin × Clear all
NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Minia University

Phase 1/2 Completed
56 enrolled

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡